| 股票 | 富途行业 | PE | PB | 股息率 | 分红率 | 毛利率 | ROE | 固定资产 | 负债率 | OCF/市值 | 营收增速 | 利润增速 | 近60日 | YTD | 近一年 | 距52周高 | 市值亿 ▴ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 新细胞医学 GDTC | 生物技术 | -3.2 | 1.98 | 0.0% | — | 79% | -51% | 30% | 14% | -28.3% | +394% | -68% | -19% | -36% | -53% | 23% | 0 |
| Enlivex ENLV | 生物技术 | 0.0 | 0.01 | 0.0% | 0% | — | 126% | — | 17% | -54.2% | +0% | +8329% | -89% | -90% | -93% | 4% | 0 |
| Actinium ATNM | 生物技术 | 2.9 | 1.07 | 0.0% | 0% | — | -167% | 2% | 85% | -70.0% | +0% | +11% | -2% | -24% | -36% | 59% | 0 |
| Kyntra Bio KYNB | 生物技术 | 0.2 | -1.15 | 0.0% | 0% | 91% | 0% | — | 96% | -109.9% | -78% | +486% | +28% | -3% | -23% | 68% | 0 |
| ALPS GROUP INC ALPS | 生物技术 | -19.0 | -21.11 | 0.0% | — | 32% | 0% | 50% | 146% | -4.1% | +44% | +20% | -44% | -56% | -96% | 2% | 1 |
| Spero Therapeutics SPRO | 生物技术 | 8.6 | 1.59 | 0.0% | 0% | — | 16% | 1% | 14% | 27.8% | +39% | +112% | -52% | -48% | -39% | 39% | 1 |
| Champions Oncology CSBR | 生物技术 | -65.2 | 18.45 | 0.0% | — | 48% | -30% | 35% | 85% | -6.2% | +4% | -125% | -9% | -24% | -23% | 60% | 1 |
| Rallybio RLYB | 生物技术 | 2.1 | 0.95 | 0.0% | 0% | — | -15% | 1% | 7% | 29.7% | +35% | +84% | +6% | +208% | +256% | 96% | 1 |
| 伊芙美尔医疗 ICCC | 生物技术 | 141.4 | 2.87 | 0.0% | 0% | 41% | -4% | 54% | 36% | 6.6% | +4% | +52% | +2% | +61% | +51% | 82% | 1 |
| Oramed Pharmaceuticals ORMP | 生物技术 | 1.2 | 0.66 | 5.0% | 6% | 1% | 37% | 0% | 14% | -2.5% | +0% | +435% | +35% | +89% | +134% | 92% | 2 |
| Protalix Biotherapeutics PLX | 生物技术 | 11.6 | 3.01 | 0.0% | 0% | 49% | -14% | 31% | 41% | 4.6% | -1% | -325% | +36% | +48% | +69% | 84% | 2 |
| Clinuvel Pharmaceuticals CUVL | 生物技术 | 13.6 | 1.67 | 0.5% | 7% | 83% | 13% | 2% | 8% | 0.0% | +4% | -1% | +5% | -23% | -22% | 73% | 3 |
| Q32 Bio QTTB | 生物技术 | 3.8 | 3.37 | 0.0% | 0% | — | 125% | 5% | 32% | -5.6% | +0% | +162% | -7% | +261% | +585% | 51% | 4 |
| 艾吉纳斯 AGEN | 生物技术 | 2.8 | -1.86 | 0.0% | 0% | 30% | 0% | 32% | 222% | -26.6% | +10% | +99% | +168% | +162% | +93% | 93% | 4 |
| Arvinas ARVN | 生物技术 | 36.1 | 1.09 | 0.0% | 0% | — | -16% | 2% | 40% | -33.7% | -0% | +59% | +34% | -21% | +18% | 65% | 6 |
| Assembly Biosciences ASMB | 生物技术 | 29.5 | 2.44 | 0.0% | 0% | — | -5% | 1% | 20% | -5.2% | +154% | +85% | +64% | +8% | +57% | 92% | 7 |
| Arbutus Biopharma ABUS | 生物技术 | 6.5 | 3.94 | 0.0% | 0% | — | -38% | 4% | 19% | -2.4% | +128% | +52% | +25% | +7% | +26% | 94% | 10 |
| 奥麦罗制药 OMER | 生物技术 | 11.0 | -26.73 | 0.0% | 0% | — | 0% | — | 137% | -5.0% | +0% | +98% | +86% | +10% | +350% | 96% | 14 |
| Vor Biopharma VOR | 生物技术 | 2.2 | -7.40 | 0.0% | 0% | — | 0% | — | 135% | -9.5% | +0% | -495% | +93% | +92% | -37% | 50% | 15 |
| Lakefront Biotherapeutics LKFT | 生物技术 | 2.7 | 0.49 | 0.0% | 0% | 97% | 10% | 2% | 5% | -14.1% | +356% | +389% | -0% | -13% | -15% | 75% | 19 |
| Vericel VCEL | 生物技术 | 83.7 | 5.56 | 0.0% | 0% | 74% | 5% | 22% | 27% | 3.4% | +16% | +59% | +8% | +12% | +21% | 82% | 21 |
| Royalty Pharma RPRX | 生物技术 | 34.4 | 4.17 | 1.4% | 49% | — | 12% | — | 50% | 10.5% | +5% | -0% | +18% | +68% | +82% | 99% | 285 |
| 再生元制药公司 REGN | 生物技术 | 20.5 | 2.69 | 0.4% | 9% | 85% | 15% | 9% | 23% | 5.5% | +1% | +2% | +38% | +8% | +49% | 96% | 852 |
点表头排序。市值单位亿美元;财务为最近年报(futu 筛选器);分红率 = 股息率 × PE;OCF/市值 = 经营现金流 ÷ 市值(无 FCF);距52周高 = 现价 / 52 周最高。